Drug
RT 310
RT 310: highest development phase Phase 2, developed by Resurge Therapeutics Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Resurge Therapeutics Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| RT-310 NCT07928206 | Phase 2 | Benign Prostatic Hyperplasia (BPH) |
Latest
No recent events.
Follow RT 310 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.